We tried to examine if there is a particular distribution pattern of lipopr
otein(a) [Lp(a)] phenotypes specific for patients with vascular dementia (V
D). Fourteen cases of VD (9 males and 5 females), 18 cases of dementia of t
he Alzheimer type (DAT)(7 males and 11 females), 29 cases of cerebrovascula
r disease (CVD) in the chronic phase (18 males and 11 females) and 47 healt
hy individuals as controls (25 males and 22 females) were examined for seru
m Lp(a). Serum concentrations and phenotypes of Lp(a) were assessed by ELIS
A and a test kit for the Lp(a) phenotype, respectively. Serum concentration
s of Lp(a) were significantly higher in patients with VD (p < 0.05) as well
as patients with CVD (p < 0.01) compared with those in healthy individuals
. Serum concentrations of Lp(a) did not significantly differ between patien
ts with DAT and healthy individuals. The incidences of Lp(a) phenotypes con
taining relatively low-molecular-weight apolipoprotein(a) isoforms were sig
nificantly higher in patients with CVD in the chronic phase (p < 0.05) or t
hose with VD (p < 0.01) compared with those in healthy individuals. Distrib
ution patterns of Lp(a) phenotypes did not differ between patients with DAT
and healthy individuals. Thus, high serum levels of Lp(a) could be conside
red a clinical hallmark to distinguish VD from DAT. Abnormally high serum l
evels of Lp(a) in patients with CVD and VD seemed to be due to specific inc
reases in low-molecular-weight apolipoprotein(a) isoforms in Lp(a). Copyrig
ht (C) 2000 S. Karger AG, Basel.